Options Expiry Day Shakes Up Chips, Bears, and a Big Deal
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Triple Witching Hits Today
June options expiry — a triple-witching event — is shaping markets on June 15. NVDA carries the deepest options chain of any stock, with 29 active expiry dates. Chip stocks fell last week then bounced hard, creating heavy near-term swing trading activity. TSLA faces added pressure today after Reuters reported the company gave European regulators misleading Full Self-Driving safety data. Put interest in near-dated Tesla contracts looks elevated.
Qualcomm Eyes an AI Chip Deal
The biggest deal story of the day: QCOM is in talks to acquire AI chip startup Tenstorrent at a valuation of $8B–$10B, according to The Information. The move would expand Qualcomm's AI silicon capabilities. It adds to a week already defined by heavy chip-sector activity, with analysts quietly raising targets on TXN and ON.
Short Sellers Stay Busy
Bears made aggressive moves this week. CBRS short interest spiked 24 percentage points to 30.3% of free float. Borrow availability is just 0.6% — new shorts are nearly impossible to open. CELH also saw SI jump 22% to 18.7% of float, even as broader markets rallied.
Big Insiders Cash Out
DELL saw $776M in Silver Lake share sales between June 2–10. NVDA director Mark Stevens filed a $199M sale on June 4. The Walton family filed $510M in WMT sales across late May and early June — five separate filings in under two weeks.
Gilead Gets FDA Nod
GILD received FDA acceptance of a supplemental application for its Yeztugo 300mg tablet today. The regulator set a February 2, 2027 action date. Healthcare names are active across both short interest and options markets this week.
Stocks in this article
How this article was generated
- Generated
- 15 Jun 2026, 20:50
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowORTEX Alpha signalsORTEX Alpha signalsAnalyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.